Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Net Margin (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Net Margin readings, the most recent being 1084.4% for Q4 2025.

  • On a quarterly basis, Net Margin fell 12024.0% to 1084.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 1492.2%, a 27211.0% decrease, with the full-year FY2025 number at 1501.47%, down 28138.0% from a year prior.
  • Net Margin hit 1084.4% in Q4 2025 for Lucid Diagnostics, down from 866.42% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 657.33% in Q2 2025 to a low of 18880.26% in Q3 2022.
  • Median Net Margin over the past 5 years was 1814.56% (2023), compared with a mean of 4206.88%.
  • Biggest five-year swings in Net Margin: crashed -1540176bps in 2022 and later surged 1706570bps in 2023.
  • Lucid Diagnostics' Net Margin stood at 3768.67% in 2021, then plummeted by -254bps to 13328.57% in 2022, then surged by 92bps to 1041.35% in 2023, then rose by 7bps to 964.16% in 2024, then decreased by -12bps to 1084.4% in 2025.
  • The last three reported values for Net Margin were 1084.4% (Q4 2025), 866.42% (Q3 2025), and 657.33% (Q2 2025) per Business Quant data.